Prostate Cancer Postdoctoral Training Program
Prostate cancer research at Cedars-Sinai encompasses everything from molecular genetics, biochemical analyses and comparative animal research, to clinical investigation, therapeutic trials and health services research.
Prostate cancer is the second leading cause of cancer-related death in males in the U.S., with 174,650 new cases and 31,620 deaths estimated in 2019. There is great promise in prevention, early detection, distinction of indolent and aggressive disease, and novel treatments. Many unmet clinical needs require better understanding of:
- Prostate cancer genomics and signaling
- How the tumor interacts with its microenvironment
- The development of novel therapeutics strategies
- Understanding risk factors
- Variations in treatment patterns that lead to optimal care delivery
About Our Training
How to Apply
We are looking for highly motivated trainees for our Prostate Cancer Training Program T32 supported by the NCI/NIH. Our primary objective is to help fellows become productive research scientists capable of establishing independent scientific careers in prostate cancer research.
Interviews are by invitation. Cedars-Sinai doesn't discriminate on the basis of sex, race, color, or national or ethnic origin.
Additional Program Information
Types of Research
The genitourinary cancer tumor boards include medical, surgical, radiation oncologists, pathologists, and many other disciplines, as well as fellows. Patient cases, radiology images, and pathology results are reviewed and experts recommend the best course of treatment and a care plan is developed.
Prostate cancer clinical trials underway at Cedars-Sinai explore various facets of the disease, including possible new treatment options—from surgery to radiation—as well as new diagnostic, imaging and genetic-based advancements.
The mentors of this unique and collaborative training program are committed to training young scientists in interdisciplinary translational research. The faculty, at the forefront of prostate cancer research and patient care, are united in recruiting and training talented minds that will perform interdisciplinary research at the Samuel Oschin Comprehensive Cancer Institute.
Have Questions or Need Help?
Contact us if you have questions or would like to learn more about Cedars-Sinai Prostate Cancer NIH Funded Training Program.
Neil Bhowmick, PhD
Professor and Co-Director of Cancer Biology
8750 Beverly Blvd., Atrium Building Rm 103
Los Angeles, CA 90048
Stephen Freedland, MD
Professor and Co-Director of Prevention and Control
8500 Beverly Blvd., East Tower
Los Angeles, CA 90048